New York State Partners with BioReference Laboratories to Spearhead the NY Forward COVID-19 Rapid Test Program to Help Reopen the New York EconomyPRNewsWire • 02/22/21
Opko Health's Q4 Service Revenues More Than Double Due To COVID-19 Testing ServicesBenzinga • 02/19/21
OPKO Health, Inc. (OPK) CEO Dr. Phillip Frost on Q4 2020 Results - Earnings Call TranscriptSeeking Alpha • 02/19/21
OPKO Health to Report Fourth Quarter 2020 Financial Results on February 18, 2021GlobeNewsWire • 02/03/21
OPKO Health, Inc. (OPK) CEO Phil Frost Presents at 39th Annual JPMorgan Virtual Healthcare Conference (Transcript)Seeking Alpha • 01/13/21
OPKO Health's BioReference Laboratories Introduces Scarlet Health™, an In-Home Diagnostic Service to Expand Digital Health AccessPRNewsWire • 01/13/21
Sian Capital Urges OPKO Health to Address Apparently Misleading 4Q'20 GuidanceGlobeNewsWire • 01/13/21
OPKO Health's BioReference Laboratories Reports Results of the Largest COVID-19 Public School Testing Program NationwidePRNewsWire • 01/04/21
US FDA Accepts Regulatory Submission from Pfizer and OPKO for Review of Somatrogon to Treat Pediatric Patients with Growth Hormone DeficiencyBusiness Wire • 01/04/21